Riskpilot← Back to searchSign inGet full accessOM Instrumenter ApS
APSDissolvedCVR 19300196Kappa 3Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19961 employees
Revenue 2024
DKK 914K
-61% vs 2023
EBITDA margin
-47.3%
-196% vs 2023
Equity ratio
87.6%
Financial strength
Net profit 2024
DKK -319K
-196% vs 2023
| Revenue | DKK 914K | -61% |
| EBITDA | DKK -432K | -196% |
| Net profit | DKK -319K | -196% |
| Total assets | DKK 3,2M | -34% |
| Equity | DKK 2,8M | -14% |
| Employees | 1 | — |
Legal name
OM Instrumenter ApS
CVR number
19300196
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
28. maj 1996
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Address
Kappa 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.077 | 3.222 | 3.166 | 3.539 | 4.483 | 4.495 | 2.904 | 2.069 | 1.869 | 2.650 | 2.500 | 2.344 | 914 |
| Staff expenses | -1.960 | -2.992 | -2.889 | -3.240 | -4.217 | -4.154 | -2.707 | -1.912 | -1.430 | -1.584 | -1.505 | -1.893 | -1.346 |
| EBITDA | 117 | 230 | 277 | 299 | 266 | 341 | 197 | 157 | 485 | 1.066 | 995 | 451 | -432 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 117 | 230 | 277 | 299 | 266 | 341 | 197 | 157 | 485 | 1.066 | 995 | 451 | -432 |
| Net financials | -48 | -98 | -58 | -75 | -36 | -97 | -66 | -33 | -37 | -19 | -17 | -14 | 24 |
| Profit before tax | 69 | 133 | 219 | 224 | 230 | 244 | 131 | 123 | 448 | 1.047 | 978 | 437 | -408 |
| Tax | 21 | 34 | 55 | 54 | 52 | 55 | 31 | 29 | 103 | 240 | 220 | 104 | -89 |
| Net profit | 49 | 99 | 164 | 170 | 178 | 189 | 100 | 95 | 344 | 807 | 758 | 333 | -319 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4.747 | 5.575 | 5.378 | 6.636 | 7.510 | 8.606 | 6.166 | 7.284 | 7.167 | 4.458 | 4.674 | 4.764 | 3.158 |
| Equity | 505 | 604 | 768 | 938 | 1.116 | 1.305 | 1.405 | 1.500 | 1.789 | 2.446 | 3.054 | 3.237 | 2.767 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4.243 | 4.971 | 4.610 | 5.698 | 6.394 | 7.301 | 4.761 | 5.784 | 5.378 | 2.012 | 1.620 | 1.527 | 391 |
| Total debt | 4.243 | 4.971 | 4.610 | 5.698 | 6.394 | 7.301 | 4.761 | 5.784 | 5.378 | 2.012 | 1.620 | 1.527 | 391 |
EBITDA margin
-47.3%
This company
15.8%
Market median
-399% vs market
20122024
Equity ratio
87.6%
This company
38.2%
Market median
+129% vs market
20122024
Return on equity
-11.5%
This company
18.4%
Market median
-163% vs market
20122024
Net profit margin
-34.9%
This company
8.1%
Market median
-531% vs market
20122024
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
20122024
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
US Management | Management | 1996 | — | — |
ET | Audit | 1996 | — | — |
AM Management | Management | 2020 | — | — |
KP Management | Management | 1996 | — | — |
MN Management | Management | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 1996 | — | — | |
| Board of Directors | 1996 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Ketipo Consulting ApS | Company | 100.0% | 100.0% | 2007 |
ONEMED A/S | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OM Instrumenter ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulf Svejgaard Poulsen | Management | 0 companies |
| Erik Tronborg Andersen | Audit | 0 companies |
| Anne Minor Christensen | Management | 0 companies |
| Kim Peter Christensen | Management | 0 companies |
| Morten Nielsen | Management | 0 companies |
| Hans Thomas Axelsson | Chairman | 0 companies |
| Per Emil Hasselbalch Stakemann | Board of Directors | 0 companies |